C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof

Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
01/1998
01/07/1998	EP0816508A1 Preparation of oligo- or polynucleotides, 2'-deoxy- or 2',3'-dideoxyfuranosides and desamino compounds of nucleosides, nucleotides, purine and pyrimidine bases by means of multifunctional enzymes
01/07/1998	EP0815114A1 Nucleic acid synthesis using photoremovable protecting groups
01/07/1998	EP0814810A1 Adenosine as a positive inotrop in the compromised heart
01/07/1998	CN1169728A Process for preparing 1-(2'-deoxy-2',2'-difluoRo-d-ribofuranosyl-4-aminopyrimidin-2-one) hydrochloride
01/06/1998	US5705630 2'-methylidenepyrimidine nucleoside compounds
01/06/1998	US5705585 Aminimide-containing molecules and materials as molecular recognition agents
01/06/1998	US5705511 Fused pyrrolocarbazoles
01/06/1998	US5705492 3'-O-aminoacyl ARA uridines, method of making, and antiviral activity
01/06/1998	US5705491 Adenosine deaminase inhibitor
01/06/1998	US5705490 Treatment of herpes or cytomegalovirus with benzimidazole deriatives
01/06/1998	US5705337 Nucleic acid detection of ligands that bind covalently with target molecule complexes
12/1997
12/31/1997	WO1997049769A1 4,7-dichlororhodamine dyes
12/31/1997	WO1997049717A1 3'-oximino-2',3'-dideoxynucleosides and derivatives of the same
12/30/1997	US5703224 Homonucleosides which are resistant to hydrolysis
12/30/1997	US5703218 Useful in biosynthesis
12/30/1997	US5703058 Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
12/30/1997	US5702924 Process for preparing antiparasitic agents
12/29/1997	EP0813539A1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom
12/29/1997	EP0813416A1 Reduction of infarct volume using citicoline
12/29/1997	EP0614462B1 New method of preparing 2-fluoropurine derivatives
12/24/1997	WO1997040006A3 Phosphate mimics
12/23/1997	US5700937 Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds
12/23/1997	US5700922 PNA-DNA-PNA chimeric macromolecules
12/23/1997	US5700919 Modified phosphoramidite process for the production of modified nucleic acids
12/23/1997	US5700916 Solution and solid-phase formation of glycosidic linkages
12/23/1997	US5700786 Dehydrogenase enzyme inhibitor for treating cancer, viral diseases
12/23/1997	US5700666 Fermentation of arabinonucleoside with aryl phosphate
12/23/1997	CA2103324C N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
12/18/1997	WO1997047637A1 Phosphotriester oligonucleotides, amidites and method of preparation
12/18/1997	WO1997047636A2 Intermediates for oligonucleotide synthesis
12/18/1997	WO1997047635A1 Processes for high-yield diastereoselective synthesis of dideoxynucleosides
12/18/1997	CA2258160A1 Processes for high-yield diastereoselective synthesis of dideoxynucleosides
12/18/1997	CA2257453A1 Intermediates for oligonucleotide synthesis
12/17/1997	EP0717748B1 2' or 3'-deoxy and 2'-dideoxy-beta-l-pentafuranonucleoside compounds, method of preparation and application in therary, especially as anti-viral agents
12/17/1997	EP0559845B1 Use of compounds in preventing endotoxin shock
12/17/1997	EP0491739B1 Multi-functional enzymes including derivable 2',3'-didesoxyribofuranoside triphoshpates
12/17/1997	EP0458901B1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity
12/17/1997	EP0275249B2 Continuous intravenous infusion of adenosine to human patients, a unit dosage form of adenosine and use of adenosine for the manufacture of medicaments
12/16/1997	US5698532 Pyrimidine nucleosides and methods for treating viral infections with same
12/11/1997	WO1997046568A1 Nucleic acid mediated electron transfer
12/11/1997	CA2257534A1 Nucleic acid mediated electron transfer
12/10/1997	EP0811011A1 Carbohydrate conjugated bio-active compounds
12/09/1997	US5696265 Antiretroviral; antitunor agent
12/09/1997	US5696255 Reacting 2-aminopurine compound in hydrogen fluoride/pyridine or hydrogen fluoride/pyridine/water in presence of nitrite
12/09/1997	US5696254 Processes for the diastereoselective synthesis of nucleoside analogues
12/09/1997	US5696253 Polynucleoside chain with 3'→5' guanidyl linkages
12/09/1997	US5696249 Nucleic acid ligands
12/09/1997	US5696248 Gene expression inhibitor, as probes for detecting nucleic acids, as viricides treating viral disease caused by htlv, influenza, hepatitis virus, papilloma virus
12/09/1997	US5696124 Xanthine derivatives with adenosine-antagonistic activity
12/09/1997	US5696097 Antineoplastic 5'-diacylglycerylphosphatidyl-2-deoxy-2'-methylenylcytidines and method of making
12/09/1997	US5695979 Using oligonucleotide
12/04/1997	WO1997041139A3 A combinatorial protecting group strategy for multifunctional molecules
12/04/1997	WO1997040458A3 Universal solid supports and methods for their use
12/03/1997	EP0810435A2 Detectable molecules, method of preparation and use
12/03/1997	EP0698033B1 Purification of fluoronucleosides
12/03/1997	EP0533838B1 Nucleic acid ligands
12/03/1997	CN1036591C Carbamates of repamycin
12/02/1997	US5693799 Phosphinates having a reactive p-h bond and a protected p-h bond can be reacted with an organic group selected from aldehyde, ketone, or a sugar having ethylenic group reactive to p-h to give product, hydrolysis to remove protected group
12/02/1997	US5693798 Phosphonate nucleoside analogs
12/02/1997	US5693791 Penicillins and cephalosporins linked to metronidazole to produce antibiotics with new properties
12/02/1997	US5693787 Stereospecific
12/02/1997	US5693524 Anticoccidial composition of UK-61 689 and Actinomadura mycelium
12/02/1997	US5693521 Membrane-permeant second messengers
12/02/1997	US5693502 Nucleic acid ligand inhibitors to DNA polymerases
11/1997
11/27/1997	WO1997044345A1 Nucleoside derivatives with photo-unstable protective groups
11/27/1997	DE19620170A1 Nucleosid-Derivate mit photolabilen Schutzgruppen Nucleoside derivatives with photolabile protecting groups
11/27/1997	CA2254065A1 Nucleoside derivatives with photoliable protective groups
11/26/1997	EP0808843A2 Novel macrolide compound 0406
11/26/1997	EP0808320A1 Novel chain terminators, the use thereof for nucleic acid sequencing and synthesis and a method of their preparation
11/26/1997	EP0719271B1 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
11/25/1997	US5691320 Acylated pyrimidine nucleosides for treatment of systemic inflammation and inflammatory hepatitis
11/25/1997	US5691319 Anticarcinogenic agents
11/25/1997	US5691307 O6 -substituted guanine compositions and methods for depleting O6
11/25/1997	US5691141 DNA sequencing by mass spectrometry
11/20/1997	WO1997043300A1 Adenosine derivatives
11/20/1997	WO1997043299A1 Alkylated nucleoside-3'-phosphates, process for producing them and their use
11/20/1997	WO1997043295A1 D-pentofuranose derivatives and process for the preparation thereof
11/20/1997	WO1997043232A1 Novel substance library and supramolecular complexes produced therewith
11/20/1997	WO1997026270A3 Synthesis of methoxy nucleosides and enzymatic nucleic acid molecules
11/20/1997	DE19632823C1 Complexes of (+)-S-adenosyl-methionine and 3'-azido-2',3'-di:deoxy nucleoside compounds
11/20/1997	DE19619373A1 Neue Substanzbibliothek und damit hergestellte supramolekulare Komplexe New compound library and supramolecular complexes produced thereby
11/20/1997	CA2252815A1 Novel substance library and supramolecular complexes prepared therewith
11/19/1997	EP0806964A1 Chemical compounds
11/19/1997	EP0806957A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir adn the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc
11/19/1997	EP0806956A1 Use of 5'substituted nucleosides to provide resistance in cytostatic treatment and medicaments containing said nucleosides
11/19/1997	EP0731807A4 N-2 substituted purines
11/19/1997	EP0720604B1 Conformationally locked nucleoside analogues
11/19/1997	EP0544792B1 Novel nucleoside analogs
11/19/1997	CN1165519A Process for purifying and isolating 2'-deoxy-2'-2'-difluoronucleosides
11/18/1997	US5688948 Intermediates for acyclovir and ganciclovir with crystallization
11/18/1997	US5688941 Methods of making conjugated 4' desmethyl nucleoside analog compounds
11/18/1997	US5688935 Cells and clots
11/18/1997	US5688802 Treatment of alzheimer's disease, organic brain syndrome, parkinson's disease, senile dementia
11/18/1997	US5688778 Nucleoside analogs
11/18/1997	US5688774 A3 adenosine receptor agonists
11/13/1997	WO1997042208A1 In situ preparation of nucleoside phosphoramidites and their use in synthesis of oligonucleotides
11/13/1997	WO1997042207A1 Nucleoside derivatives, and their use in oligonucleotide synthesis
11/13/1997	WO1997042202A1 In situ preparation of nucleoside phosphoramidites and oligonucleotide synthesis
11/13/1997	DE19618727A1 Herstellung alkylierter Nucleosid-3'-Phosphate Preparation of alkylated nucleoside-3'-phosphates
11/13/1997	CA2253895A1 Nucleoside derivatives, and their use in oligonucleotide synthesis

1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 201